Table of Contents

Articles

• You have access

  Differential Signaling by Splice Variants of the Human Free Fatty Acid Receptor GPR120

  Sarah-Jane Watson, Alastair J. H. Brown and Nicholas D. Holliday

  Molecular Pharmacology May 2012, 81 (5) 631-642; DOI: https://doi.org/10.1124/mol.111.077388
• You have access

  Cinnabarinic Acid, an Endogenous Metabolite of the Kynurenine Pathway, Activates Type 4 Metabotropic Glutamate Receptors

  F. Fazio, L. Lionetto, G. Molinaro, H. O. Bertrand, F. Acher, R. T. Ngomba, S. Notartomaso, M. Curini, O. Rosati, P. Scarselli, R. Di Marco, G. Battaglia, V. Bruno, M. Simmaco, J. P. Pin, F. Nicoletti and C. Goudet

  Molecular Pharmacology May 2012, 81 (5) 643-656; DOI: https://doi.org/10.1124/mol.111.074765
• You have access

  Extracellular Signal-Regulated Kinase Mitogen-Activated Protein Kinase-Dependent SOCS-3 Gene Induction Requires c-Jun, Signal Transducer and Activator of Transcription 3, and Specificity Protein 3 Transcription Factors

  Jolanta Wiejak, Julia Dunlop, Shan Gao, Gillian Borland and Stephen J. Yarwood

  Molecular Pharmacology May 2012, 81 (5) 657-668; DOI: https://doi.org/10.1124/mol.111.076976
• You have access

  The Aryl Hydrocarbon Receptor Contributes to the Proliferation of Human Medulloblastoma Cells

  Daniel P. Dever and Lisa A. Opanashuk

  Molecular Pharmacology May 2012, 81 (5) 669-678; DOI: https://doi.org/10.1124/mol.111.077305
• You have access

  Regulation of Interferon-Inducible Proteins by Doxorubicin via Interferon γ-Janus Tyrosine Kinase-Signal Transducer and Activator of Transcription Signaling in Tumor Cells

  J. Hussner, S. Ameling, E. Hammer, S. Herzog, L. Steil, M. Schwebe, J. Niessen, H. W. S. Schroeder, H. K. Kroemer, C. A. Ritter, U. Völker and S. Bien

  Molecular Pharmacology May 2012, 81 (5) 679-688; DOI: https://doi.org/10.1124/mol.111.075994
• You have access

  Agonist-Dependent Potentiation of Vanilloid Receptor Transient Receptor Potential Vanilloid Type 1 Function by Stilbene Derivatives

  Xuan Zhang, Xiao-Na Du, Guo-Hong Zhang, Zhan-Feng Jia, Xing-Juan Chen, Dong-Yang Huang, Bo-Yi Liu and Hai-Lin Zhang

  Molecular Pharmacology May 2012, 81 (5) 689-700; DOI: https://doi.org/10.1124/mol.111.076000
• You have access

  Human Papilloma Virus 16 E6 RNA Interference Enhances Cisplatin and Death Receptor-Mediated Apoptosis in Human Cervical Carcinoma Cells

  Shinta Tan, Brigitte M. T. Hougardy, Gert J. Meersma, Bessel Schaap, Elisabeth G. E. de Vries, Ate G. J. van der Zee and Steven de Jong

  Molecular Pharmacology May 2012, 81 (5) 701-709; DOI: https://doi.org/10.1124/mol.111.076539
• You have access

  A Series of α7 Nicotinic Acetylcholine Receptor Allosteric Modulators with Close Chemical Similarity but Diverse Pharmacological Properties

  JasKiran K. Gill, Persis Dhankher, Tom D. Sheppard, Emanuele Sher and Neil S. Millar

  Molecular Pharmacology May 2012, 81 (5) 710-718; DOI: https://doi.org/10.1124/mol.111.076026
• You have access

  Anticancer Activity of Methyl-Substituted Oxaliplatin Analogs

  Ute Jungwirth, Dimitris N. Xanthos, Johannes Gojo, Anna K. Bytzek, Wilfried Körner, Petra Heffeter, Sergey A. Abramkin, Michael A. Jakupec, Christian G. Hartinger, Ursula Windberger, Markus Galanski, Bernhard K. Keppler and Walter Berger

  Molecular Pharmacology May 2012, 81 (5) 719-728; DOI: https://doi.org/10.1124/mol.111.077321
• You have access

  Ligand-Specific Roles for Transmembrane 5 Serine Residues in the Binding and Efficacy of Dopamine D₁ Receptor Catechol Agonists

  Benjamin R. Chemel, Lisa A. Bonner, Val J. Watts and David E. Nichols

  Molecular Pharmacology May 2012, 81 (5) 729-738; DOI: https://doi.org/10.1124/mol.111.077339
• You have access

  Time-Dependent Interaction between Differentiated Embryo Chondrocyte-2 and CCAAT/Enhancer-Binding Protein α Underlies the Circadian Expression of CYP2D6 in Serum-Shocked HepG2 Cells

  Naoya Matsunaga, Miki Inoue, Naoki Kusunose, Keisuke Kakimoto, Kengo Hamamura, Yuichi Hanada, Ayumi Toi, Yuji Yoshiyama, Fuyuki Sato, Katsumi Fujimoto, Satoru Koyanagi and Shigehiro Ohdo

  Molecular Pharmacology May 2012, 81 (5) 739-747; DOI: https://doi.org/10.1124/mol.111.076406
• You have access

  Lapatinib and Obatoclax Kill Tumor Cells through Blockade of ERBB1/3/4 and through Inhibition of BCL-xL and MCL-1

  Nichola Cruickshanks, Hossein A. Hamed, M. Danielle Bareford, Andrew Poklepovic, Paul B. Fisher, Steven Grant and Paul Dent

  Molecular Pharmacology May 2012, 81 (5) 748-758; DOI: https://doi.org/10.1124/mol.112.077586